Abstract:Clinical development of antibiotics with novel mechanisms of action to kill pathogenic bacteria is challenging, in part, due to the inevitable emergence of resistance. A phenomenon of potential clinical importance that is broadly overlooked in preclinical development is heteroresistance, an often-unstable phenotype in which sub-populations of bacterial cells show decreased antibiotic susceptibility relative to the dominant population. Here, we describe a new globomycin analog, G0790, with potent activity against the Escherichia coli type II signal peptidase LspA and uncover two novel resistance mechanisms to G0790 in the clinical uropathogenic E. coli strain CFT073. Building on the previous finding that complete deletion of Lpp, the major Gram-negative outer membrane lipoprotein, leads to globomycin resistance, we also find that an unexpectedly modest decrease in Lpp levels mediated by insertion-based disruption of regulatory elements is sufficient to confer G0790 resistance and increase sensitivity to serum killing. In addition, we describe a heteroresistance phenotype mediated by genomic amplifications of lspA that result in increased LspA levels sufficient to overcome inhibition by G0790 in culture. These genomic amplifications are highly unstable and are lost after as few as two subcultures in the absence of G0790, which places amplification-containing resistant strains at high risk of being misclassified as susceptible by routine antimicrobial susceptibility testing. In summary, our study uncovers two vastly different mechanisms of resistance to LspA inhibitors in E. coli and emphasizes the importance of considering the potential impact of unstable and heterogenous phenotypes when developing antibiotics for clinical use. IMPORTANCE Despite increasing evidence suggesting that antibiotic heteroresistance can lead to treatment failure, the significance of this phenomena in the clinic is not well understood, because many clinical antibiotic susceptibility testing approaches lack the resolution needed to reliably classify heteroresistant strains. Here we present G0790, a new globomycin analog and potent inhibitor of the Escherichia coli type II signal peptidase LspA. We demonstrate that in addition to previously known mechanisms of resistance to LspA inhibitors, unstable genomic amplifications containing lspA can lead to modest yet biologically significant increases in LspA protein levels that confer a heteroresistance phenotype.

Deletion of PBP1a/LpoA Complex Compromises Cell Envelope Integrity in Shewanella Oneidensis

PBP1a Glycosyltransferase and Transpeptidase Activities Are Both Required for Maintaining Cell Morphology and Envelope Integrity in Shewanella Oneidensis

PBP1a/LpoA but Not PBP1b/LpoB Are Involved in Regulation of the Major Β-Lactamase GeneblaAin Shewanella Oneidensis

Deletion of Lytic Transglycosylases Increases Beta-Lactam Resistance in Shewanella Oneidensis.

Expression of Blaa Underlies Unexpected Ampicillin-Induced Cell Lysis of Shewanella Oneidensis.

Distinct Roles of Major Peptidoglycan Recycling Enzymes in Β-Lactamase Production in Shewanella Oneidensis

Lipopolysaccharide Transport System Links Physiological Roles of Σe and ArcA in the Cell Envelope Biogenesis in Shewanella Oneidensis.

Impaired Cell Envelope Resulting from Arca Mutation Largely Accounts for Enhanced Sensitivity to Hydrogen Peroxide in Shewanella Oneidensis.

Peptidoglycan Association of Murein Lipoprotein is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia Coli Isolate

Reduced peptidoglycan synthesis capacity impairs growth of E. coli at high salt concentration

Structure of the essential inner membrane lipopolysaccharide-PbgA complex

Functional Assessment of Envz/Ompr Two-Component System in Shewanella Oneidensis

Unstable Mechanisms of Resistance to Inhibitors of Escherichia Coli Lipoprotein Signal Peptidase.

The Stringent Starvation Protein SspA Modulates Peptidoglycan Synthesis by Regulating the Expression of Peptidoglycan Synthases.

A Novel Peptidoglycan Binding Protein Crucial for PBP1A-Mediated Cell Wall Biogenesis in Vibrio cholerae

PBP-A, a cyanobacterial dd-peptidase with high specificity for amidated muropeptides, exhibits pH-dependent promiscuous activity harmful to Escherichia coli

Disruption Of Lipid Homeostasis In The Gram-Negative Cell Envelope Activates A Novel Cell Death Pathway

Simultaneously inhibiting undecaprenyl phosphate production and peptidoglycan synthases promotes rapid lysis in Escherichia coli

The A226D Mutation of OmpC Leads to Increased Susceptibility to β-Lactam Antibiotics in Escherichia coli

Involvement of the Actinobacillus Pleuropneumoniae Ompw Gene in Confrontation of Environmental Pressure.

NlpI-Prc Proteolytic Complex Mediates Peptidoglycan Synthesis and Degradation via Regulation of Hydrolases and Synthases in Escherichia coli